These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1379685)

  • 21. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
    Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
    Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services
    Natl Toxicol Program Tech Rep Ser; 2002 May; (504):1-357. PubMed ID: 12087420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring relationships between mutagenic and carcinogenic potencies.
    Piegorsch WW; Hoel DG
    Mutat Res; 1988 Sep; 196(2):161-75. PubMed ID: 3419441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests.
    Kirkland D; Kasper P; Martus HJ; Müller L; van Benthem J; Madia F; Corvi R
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Jan; 795():7-30. PubMed ID: 26774663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental design constraints on carcinogenic potency estimates.
    Rieth JP; Starr TB
    J Toxicol Environ Health; 1989; 27(3):287-96. PubMed ID: 2754755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of carcinogenic potency by short-term genotoxicity tests.
    Ennever FK; Rosenkranz HS
    Mutagenesis; 1987 Jan; 2(1):39-44. PubMed ID: 3331693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenic activity of carcinogens detected in transgenic rodent mutagenicity assays at dose levels used in chronic rodent cancer bioassays.
    Schmezer P; Eckert C; Liegibel UM; Zelezny O; Klein RG
    Mutat Res; 1998 Sep; 405(2):193-8. PubMed ID: 9748572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new approach to evaluating carcinogenic risk.
    Pariza MW
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):860-1. PubMed ID: 1736302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
    McGregor D
    Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
    Bolt HM; Degen GH
    Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotoxicity--threshold or not? Introduction of cases of industrial chemicals.
    Bolt HM
    Toxicol Lett; 2003 Apr; 140-141():43-51. PubMed ID: 12676450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International Commission for Protection Against Environmental Mutagens and Carcinogens. The subtlety of alkylating agents in reactions with biological macromolecules.
    Vogel EW; Nivard MJ
    Mutat Res; 1994 Feb; 305(1):13-32. PubMed ID: 7508544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemicals classified by IARC: their potency in tests for carcinogenicity in rodents and their genotoxicity and acute toxicity.
    McGregor DB
    IARC Sci Publ; 1992; (116):323-52. PubMed ID: 1428089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of 'genotoxic' and 'non-genotoxic' alerts for cancer in mice: the carcinogenic potency database.
    Cunningham AR; Rosenkranz HS; Zhang YP; Klopman G
    Mutat Res; 1998 Feb; 398(1-2):1-17. PubMed ID: 9626960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals.
    Gold LS; Slone TH; Stern BR; Bernstein L
    Mutat Res; 1993 Mar; 286(1):75-100. PubMed ID: 7678909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-genotoxic carcinogens. Approaches to their risk assessment.
    Castro JA; Díaz Gómez MI; Castro GD
    Biomed Environ Sci; 1993 Mar; 6(1):71-80. PubMed ID: 8476535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of structural features and associated mechanisms of action for carcinogens in rats.
    Cunningham AR; Klopman G; Rosenkranz HS
    Mutat Res; 1998 Aug; 405(1):9-27. PubMed ID: 9729240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal mouse model: review of methods and results.
    McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
    Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.